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ABSTRACT 
Objective 
In UKCTOCS self-reported visualization rates(srVR) at annual TVS scan was a key 
quality control(QC) metric. Our objective was to independently assess srVR using 
expert review and develop software capable of monitoring it.  
Methods 
Images from 1,000 examinations randomly selected from 68,951 archived annual TVS 
exams undertaken between 2008-2011 where the ovaries were reported as ‘seen and 
normal’ were reviewed by a single expert. Software was developed to identify exact 
images used to measure ovaries by measuring caliper dimensions and matching them 
to that recorded by the sonographer. A logistic regression classifier to determine 
visualization was trained and validated using ovarian dimension and visualization data 
reported by the expert . 
Results 
The expert confirmed both ovaries were visualized (cVR-Both) in 50.2%(502/1000) of 
the exams. The software identified the measurement image in 534 exams which were 
split 2:1:1 providing training, validating and testing data. Classifier accuracy on 
validation data was 70.9%(CI-95% 70.0,71.8). Analysis of test data (133 exams) 
resulted in sensitivity of 90.5%(CI-95% 80.9,95.8) and specificity of 47.5%(CI-95% 
34.5,60.8) in detecting expert confirmed cVR-Both.  
Conclusions 
Our results suggest that in a significant proportion of TVS annual screens the 
sonographers may have mistaken other structures for normal ovaries. It is uncertain 
whether or not this affected the sensitivity and stage at detection of ovarian cancer in 
the ultrasound arm of UKCTOCS, but we conclude QC metrics based on self-reported 
visualization of normal ovaries are unreliable. The classifier shows some potential for 
addressing this problem, though further research is needed.  
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INTRODUCTION  
Transvaginal ultrasound (TVS) is widely used for pelvic imaging both in the 
context of patient management and in ovarian cancer screening. Visualization 
of ovaries is a desired prerequisite but can be challenging in older women as 
the ovaries are typically shrunken or more difficult to locate. 
Visualization rate (VR) is a widely used quality control (QC) metric for TVS 
scanning in the context of ovarian cancer screening.1 It is the percentage of all 
exams performed by the sonographer in which the ovaries are identified. 
However, there is  variation across different studies in terms of how VR is 
defined with some reporting visualization of both ovaries (VR-Both) and some of 
one or both ovaries (Table 1).1-6 We believe that in the context of ovarian cancer 
screening, VR-both is the more meaningful metric as early cancer can begin in 
one ovary before spreading to the contralateral ovary.  
Obtaining reliable VR data is challenging as ovarian visualization is subjective 
and sensitive to inter/intra observer variation.7 VR is also problematic as all 
previous studies1-6 8 9 have calculated ovarian VR using visualization data self-
reported by the sonographer. In UKCTOCS self-reported VR was the QC metric 
used during annual ultrasound screening. However, static ultrasound images 
taken at the time of the exam were centrally archived so an apportunity was 
provided to retrospectively investigate whether ovarian visualization had been 
achieved. We are not aware of any previous study that has attempted such TVS 
validation apart from our group’s audit of seven sonographers reporting high VR 
(Stott et al, manuscript in preparation).10 
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In this current study we report on a retrospective expert review of archived static 
images from a random sample of annual TVS examinations classified as normal 
and performed between 2008-2011 after accreditation had been introduced and 
quality monitoring had been improved.2 Our study also attempts to address the 
problem of obtaining an objective measure of VR free from inter/intra observer 
variability by constructing a software classifier trained using data from the 
expert review with the aim of helping to drive future quality improvement in TVS. 
 
METHODS 
UKCTOCS is a multicentre randomized control trial involving 202,638 women 
volunteers from 13 trial centres (TC) in England, Wales and Northern Ireland. 
Inclusion criteria were postmenopausal women aged between 50-74 years at 
recruitment. Women with previous ovarian malignancy, bilateral oophorectomy, 
active non-ovarian malignancy, increased risk of familial ovarian cancer or 
participants in other ovarian cancer screening trials were excluded. The women 
were randomised into three groups: 1) ultrasound screening; n= 50,639, 2) 
multimodal screening using CA125 interpreted by the Risk of Ovarian Cancer 
(ROC) algorithm; n=50,640, 3) no screening (control); n=101,359.11 Those in 
the ultrasound group underwent annual screening using TVS or a 
transabdominal (TAS) scan when a TVS was not acceptable to the volunteer. 
The details of the ultrasound screening process and its reporting have been 
previously described.2 An important part of the exam results were capturing the 
dimensions of each ovary in two orthogonal planes which allowed ovary volume 
to be calculated. Annual screening in the ultrasound arm of UKCTOCS occurred 
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between 4th July 2001 and 21st December 2011. 48,250 volunteers received a 
total of 328,867 annual ultrasound screens of which 300,027 were TVS exams.  
A bespoke Trial Management System (TMS) implemented the algorithm 
described in the trial protocol for categorising TVS exams as abnormal, 
unsatisfactory or normal based on data reported by the sonographer for each 
ovary (Figure 2). This data included measurements (D1, D2, D3) for left (LO) 
and right ovary (RO) copied from values displayed by the ultrasound machine 
after the sonographer had placed calliper marks on the boundaries of the ovary 
in a static image captured for this purpose. A further bespoke computer system 
called the Ultrasound Record Archive (URA) was developed to archive these 
static images as reported elsewhere.12  
The images from 216,152 TVS exams (72% of all TVS annual scans performed 
by UKCTOCS) were archived in the URA of which 113,092 exams were 
performed after January 2008 when quality monitoring had been improved, 
accreditation had been introduced and the ultrasound machine at all 13 trial 
centres were upgraded to Accuvix XQ model (Medison, Seoul, South Korea).2 
These later exams were performed by 141 sonographers all accredited to 
perform annual (level 1) TVS exams.1  
The archived images from the random selection of 1,000 normal exams were 
used for the study dataset. The inclusion criteria for the exams were: a) annual 
TVS exams of women in the ultrasound screening group; b) images stored in 
the URA; c) performed after 1st January 2008; d) both ovaries measured / 
visualized; e) both ovaries categorised as having normal morphology. TAS only 
exams and those categorized as abnormal or unsatisfactory were excluded.  
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Expert Review 
Images associated with each of the 1000 exams in the dataset were copied 
from the URA as 640 x 480 pixel greyscale bitmap files. A spreadsheet was 
prepared containing hyperlinks to these images so the reviewer could display 
them by selecting the appropriate cell, as reported elsewhere.12 Bespoke 
software was used to process the images in order to measure the calliper 
marks. The resultant dimensions were matched against the ovary dimensions 
recorded in the TMS in order to identify the exact image the sonographer had 
used to measure the ovary.12 The spreadsheet was annotated to indicate 
images that had been used to measure ovaries. However, the expert reviewed 
all the images for each exam in the dataset to detect any bias arising from 
software selection. 
A single expert in gynaecological scanning reviewed the images for each exam 
and recorded assessments of left and right ovary using one of the following 
categorical variables; visualised and correctly measured, visualised but poorly 
measured, not visualised, other images which were not of the adnexal region 
such as uterus were marked as not appropriate. Criteria used to indicate that an 
ovary was not visualised  (Figure 1) were an irregular or indistinct outline, a 
heterogeneous echogenicity of the stroma and an outline that could be be 
identified as part of a larger shape which was usually bowel. In practical terms 
the expert mentally removed the callipers and if the resulting shape did not 
resemble an ovary then the image was classed as “not visualised”. This was 
occasionally confirmed by measurements which were clearly outside the normal 
range expected for a postmenopausal ovary. 
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Construction of Logistic Regression Classifier 
Statistical learning techniques were used to construct a logistic regression 
classifier using R v3.3.2. It used the train() function provided by CARET 
(Classification and REgression Training) package v6.0.71 with the generalised 
linear model (glm) specified as its method parameter. Ovary dimensions and 
ovary type (left or right) were used as candidate feature data. Ovary 
visualization (true or false, as judged by the expert) was used as the target 
value.  
Statistical Analysis 
Visualization rates were calculated from results of the expert review of all the 
images associated with the 1,000 exams in the dataset. An ovary was defined 
as ‘seen’ when the expert reviewer categorised the image using any of the 
categorical variables ‘visualized and correctly measured’ or ‘visualized but 
poorly measured’. The use of any other categorical variables was defined as 
‘not seen’. Visualization rates were calculated for all 1,000 exams in the dataset 
using various VR definitions (Table 2) . 
The exams in the dataset were processed to create two further subsets: 1) the 
‘match’ subset containing examinations for which software found the exact 
images used by the sonographer to measure the left and right ovary. The 
software was set to only identify exams where images of the transverse and 
longitudinal planes of the ovary were saved in the “split-screen” function of the 
ultrasound machine as one image for each ovary and the software caliper 
measurements matched that reported by the sonographer. To facilitate analysis 
examinations which did not have both longitudinal section (LS) and transverse 
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section (TS) for both left and right ovary (TSLS-Both) were excluded. 2) The ‘no 
match’ subset containing the examinations for which software could not find the 
exact images used by the sonographer to measure the left and right ovary. 
Visualization Rates (VR) were calculated for the exams in both subsets using 
the definitions in Table 2 so that the differences between them could be 
assessed. 
The ‘match’ subset was randomly split in the ratio 2:1:1 (training, validation, 
test) in order to build the logistic regression classifier. Various combinations of 
features were used to constuct models from the same selection of training and 
validation data so the performance of each could be evaluated in terms of 
accuracy. The combination of features that offered best performance was 
selected and the data was randomly split using different seed values so that 
performance could be measured for different (same sized) collections of training 
and validation data as randomly selected. The following were calculated: Mean 
and 95% confidence intervals for accuracy (mean true positives plus mean true 
negatives divided by total observations for ovary dimensions in the randomly 
selected validation data); Sensitivity (mean true positives divided by sum of 
mean true positives and mean false negatives); and Specificity (mean true 
negatives divided by sum of means true negatives and mean false positives). 
Mean values for true positive, true negative, false positive,  false negatives (as 
defined in Table 3) were obtained by averaging values obtained for each 
selection of exams used as validation data as randomly split from the ‘match’ 
data subset. In this way the classifer performance metrics were not dependent 
on any particular selection of exams from the ‘match’ data subset.  
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The combination of features with the best performance was taken from exams 
in the test data and applied to the classifier. The results were recorded as 
classifier visualization; ovary visualized, or not. These results were used to 
determine visualization for each exam and these values were used to calculate 
the cVR-Both for the test data.  
 
RESULTS 
Annual TVS examinations with archived images performed after 1st January 
2008 were categorised by the TMS according to the trial protocol (Figure 2) as 
normal (105,176; 93%), abnormal (5,097;4.5%) and unsatisfactory (2,820; 
2.5%); total 113,093 exams. The dataset of 1,000 exams was randomly 
selected from 68,931 of the 105,176 normal exams that had both ovaries  
reported as ‘seen’ (visualized). This dataset had 4,654 images; mean 4.6 
images per exam and range 1-15.  
The results of the review by the one expert of images from 1,000 TVS exams 
allowed calculation of VR, but the values changed significantly depending on 
the definition used for visualization. Using a definition of both ovaries visualized 
(cVR-Both) the value of VR is 50.2%, but the VR value changes to 79.2% if a 
definition of one or both ovaries is applied (Table 2).    
The software was set to only identify exams where the transverse and 
longitudinal sections were in the same image for both ovaries and the software 
caliper measurements matched that reported by the sonographer. This was 
possible in  a ‘subset’ of 534 exams (53.4%). The images used to measure the 
ovaries were identified in a further 17 (1.7%) exams  but were excluded by the 
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software as there were multiple images. In the remaining 449 exams (44.9%) 
the images used to measure ovaries could not be recovered for the following 
reasons - 8.6% duplicate images, 16.4% unresolved, 3.9% process failure, 
16.0% images with non standard caliper marks.12 The expert VR results of 
images in this 534 exam ‘match’ subset tended to be higher than that of images 
in the remaining 466 exams ‘no-match’ subset although the difference in rates 
was not significant (Supplementary Table 1). 
The classifier’s performance was evaluated using the validation data; 268 of 
1068 ovary dimensions in the ‘match’ subset of 534 exams. Thirty different 
collections of validation data were generated by randomly splitting the subset 
using different seed values, each having feature and target data from left and 
right ovary in 134 exams; 268 total. The results of each collection were 
calculated as described in methods; mean accuracy 70.9%(CI-95% 70.0,71.8), 
mean sensitivity 93.0%(CI-95% 92.1,94.0), mean specificity 27.3%(CI-95% 
25.4,29.3). The Receiver-Operator Curve (ROC) shown in Figure 3 was 
produced from validation data in the same random split of the ‘match’ data 
subset which contained the test data used to calculate cVR-Both. 
The test data was formed by 266 ovarian dimensions from 133 exams in the 
‘match’ data subset which had not been used for training or validation. Fourty 
seven sonographers performed these exams with the number of exams by 
individual sonographers having a range of 1-15 and mean of 2.83. When the 
test data was applied to the classifier, cVR-Both was 73.7% compared with the 
gold standard of 55.6% found by the expert. The expected accuracy was 
calculated as 61.8% which gave a Kappa value of 0.24 (judged only fair 
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according to Landis Koch interpretation)13 with sensitivity 90.5% (CI-95% 
80.9,95.8) and specificity 47.5% (CI-95% 34.5,60.8) as shown in Table 3. 
 
DISCUSSION 
A retrospective review by a single expert of archived images from a random 
selection of 1,000 annual UKCTOCS TVS exams where both ovaries were 
“seen and normal”, demonstrated that the expert could definitely confirm both 
ovaries visualized in only half of the archived exams. In the remaining exams, 
the expert considered that the sonographer had mistaken some other structure 
for an ovary, most commonly bowel (Figure 1). As far as we are aware no other 
screening study has undertaken a similar independent review of normal ovarian 
scans. Our findings suggest that self-reported sonographer VR unless 
confirmed by independent review is not reliable as a QC metric and should be 
used with caution in the future. 
It is generally accepted that the success of any screening programme for 
ovarian cancer using TVS is highly dependent on sonographers finding any 
small tumours that might exist in either ovary. Models14 estimate that majority of 
high grade serous ovarian cancers progress to Stage III/IV at a median 
diameter of about 3 cm. Identifying half these tumors in Stage I/II at annual 
screen would require detection of tumors 1.3 cms in diameter but to achieve a 
50% mortality reduction it would be necessary to detect tumors 0.5 cm in 
diameter. Identifying such small tumours is very challenging even for expert 
sonographers. Therefore different levels of sonographer skill and experience 
might explain variation in outcome between the single centre Kentucky Ovarian 
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Cancer Ultrasound Screening Study6 and UKCTOCS as well as other large 
scale multicentre trials (e.g. PLCO) where it is not feasible for a small group of 
experts to deliver annual population screening.  
We cannot assess the impact on stage shift of the discrepancy between level I 
ultrasonographers and the expert on ovarian visualization in the ultrasound arm 
of UKCTOCS.15 However, all archived examinations preceding ovarian cancer 
diagnosis in the ultrasound arm of UKCTOCS were reviewed in the course of 
the trial and collation of these results should provide further insights.  
A key quality metric in all ultrasound screening trials is self-reported VR. In 
UKCTOCS, a quality monitoring programme with regular feedback was in place 
throughout.2 It included 6 monthly monitoring of self-reported VR together with 
other data such as ovarian size and missing/inaccurate information entered into 
the TMS. In addition UKCTOCS Level I sonographers with VR below 60% were 
subject to targeted training.2 To what extent these measures might have 
resulted in some sonographers designating the ovary as ‘seen’ when in doubt is 
difficult to ascertain.  
The use of statistical learning techniques to construct a logistic regression 
classifier  raises the possibility of obtaining independent reliable QC metrics that 
can be applied at low cost to large scale TVS examinations. We report on a 
classifier using ovarian dimensions to identify the ovary. However, specificity 
was low. It is possible that better performance would have been achieved had 
morphological features been included as well as ovary dimensions.  
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Strengths and Limitations  
We are not aware of any other study which has reported on a similar 
independent review of TVS examinations of archived normal TVS ovarian 
examinations. Key strengths include the scale in terms of number of 
examinations and sonographers from multiple centres reflecting the reality of a 
population ultrasound screening programme; archived images available for 72% 
of all TVS annual scans performed, random selection of examinations from 
those classified as normal and use of the exact image that was used to 
measure the ovary. A limitation was the stringent critieria used by the software 
to identify images that limited the number of images that could be assessed by 
the QC classifier. In prospective studies, this could be addressed by the 
ultrasonographer ‘flagging’ the exact ovarian images during scanning.  
A major limitations were that the review was performed by only one expert. 
Given the known subjectivity of TVS, more robust estimates of expert VR would 
have been obtained by repeat assessment of random subsets to assess both 
intra and inter observer variability. In an audit of seven sonographers reporting 
high sVR in UKCTOCS, there was significant variation in inter-observer 
agreement between six experts (Stott et al, manuscript in preparation).10 
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Other Studies 
The above audit performed in 2009 involved a similar review of the images used 
to measure ovaries from TVS exams performed by UKCTOCS sonographers. In 
this study two teams of three experts agreed that visualization of both ovaries 
could not be confirmed in a proportion of exams which had been reported as 
normal  However, further conclusions about UKCTOCS scanning quality could 
not be made due to the small number of sonographers audited (7) and the way 
they were selected. A report about this audit is currently being prepared for 
publication. 
 
Conclusion 
Our results suggest that reliable quality control for TVS cannot be achieved 
using sonographers self-reporting ovary visualization because in almost half the 
annual TVS examinations performed by UKCTOCS after Jan 2008  both ovaries 
were not visualised. The results highlight the subjective nature of grey scale 
ultrasound imaging and the role of operator experience in scanning older 
postmenopausal women. It is uncertain whether or not this affected the 
sensitivity and stage at detection in the ultrasound arm of UKCTOCS. However, 
this study does underline the challenges of delivering large-scale TVS 
screening for ovarian cancer and the need to base its quality management on 
independent as well as objective quality control metrics. In this regard the 
classifier produced for our study shows some potential, though further research 
is needed before it could be used in a TVS Quality Improvement (QI) 
programme.  
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TABLES 
Table 1: Variation in ovarian Visualization Rate (VR) on TVS related to  different 
definitions  
Table 2: Variation in expert assessed Visualization Rates using different VR 
definitions  
Table 3: Contingency table comparing Classifier to Expert visualization of both 
ovaries (cVR-Both) in the test data set 
 
Supplementary Table 1: Visualization Rates (VR) from expert review for ‘match’ 
and ‘no match’ subsets of the study dataset categorised by visualization 
definition given in Table 2. The ‘match’ subset contains exams for which the 
exact images used to measure left and right ovary can be identified by the 
software and the ‘no match’ subset contains the remaining exams 
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Trial or 
study 
Exam 
numbers 
Dates Definition of 
Visualization 
Rate (VR)  
Reported 
Visualization 
Rate (VR) 
UKCTOCS2 270,035 June 2001-Dec 
2011 
RO or both 72.7% 
One or both 84.5% 
UKCTOCS1 43,867 June 2001-Aug 
2007 
RO or both 66.8% 
LO or both 65.5% 
PLCO3 102,787 1993-2009 Both 60% 
Kentucky4 57,214 1987-1999 One or both 79.2% 
Kentucky5 120,569 1987-2005 One or both 84% 
Kentucky6 205,190 1987-2011 One or both 87.6% 
Ludovisi et al 
study8 
6649 Oct 2008-Sept 
2013 
RO or both 84.1% 
LO or both 82.4% 
Gollub et al 
study9 
206 June 1988-
Mar1989 
Both 49% 
One or both 80% 
 
Table 1: Variation in Visualization Rate (VR) in reports of TVS scanning related 
to different definitions of ovary visualization.  
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Expert VR Definition Exams with 
ovarian images 
identified by 
software 
Exams with 
ovarian images 
not identified by 
software 
All exams 
 Count 
(n=534) 
Expert 
VR %  
Count 
(n=466) 
Expert 
VR %  
Count 
(n=1000) 
Expert 
VR %    
RO or Both  
right ovary or both 
ovaries seen 
366 68.5 298 64.0 663 66.3 
LO or Both 
left ovary or both 
ovaries seen 
344 64.4 286 61.4 630 63.0 
One or Both 
left or right ovary seen 
or both ovaries seen 
430 80.5 362 77.7 792 79.2 
Both (cVR-Both) 
both ovaries seen 
280 52.4 222 47.6 502 50.2 
Table 2: Variation in expert assessed Visualization Rates using different VR 
definitions. 
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  Visualization on expert 
review 
Total Exams
Both ovaries 
visualized  
One or both 
ovaries not 
visualized 
 
Visualization 
by Classifier Both ovaries 
visualized 
67 
(True 
positives) 
31 
(False 
positives)  98 
One or both 
ovaries not 
visualized 
7(False 
negatives) 
28  
(True 
negatives) 35 
Total Exams 74 59 133 
Table 3: Contingency table comparing Classifier to Expert visualization of both 
ovaries (cVR-Both). 
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